Delivery Order SPE2DB24D3015-SPE2DB25FGAVS
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Jardiance 10 mg tablets (90-count units) with a contract ceiling value of $23,977.17. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The order is scheduled for completion by August 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Jardiance 10 mg tablets (90-count) with a ceiling value of $10,745.91. This firm fixed-price delivery order is set to be completed by August 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made on a non-set-aside, competitive basis. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Jardiance 10 mg tablets (90-count units) with a ceiling value of $8,588.52. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The order is scheduled for ultimate completion by August 19, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $1,861.15. This firm fixed-price delivery order, which is due for completion by September 4, 2025, represents a continuation of AmerisourceBergen's role as a pharmaceutical supplier to the federal government. The award carries no set-aside designation, indicating it was competitively awarded....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Jardiance 25 mg tablets (90-count) with a ceiling value of $51,243.85. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is scheduled for completion by August 21, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Jardiance 10 mg tablets (90-count) under a firm fixed price contract with a ceiling value of $12,892.13. This non-competitive, non-set-aside delivery order is scheduled for completion by August 12, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Jardiance 25 mg tablets (30-count packaging) under a firm fixed-price contract valued at $2,260.38. This non-set-aside competitive award is classified as a delivery order, with an ultimate completion date of July 29, 2025. The pharmaceutical distributor will perform this work at its corporate headquarters location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Jardiance 10 mg tablets (90-count units) with a ceiling value of $9,798.71. This competitive, non-set-aside award is structured as a firm fixed price delivery order with an ultimate completion date of August 11, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $7,563.77 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Jardiance 10 mg tablets (90-count package). This firm fixed-price delivery order, with an ultimate completion date of August 5, 2025, represents a competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Jardiance 10 mg tablets (90-count) valued at $14,902.44 under a firm fixed price contract. This is a non-set-aside delivery order with an ultimate completion date of August 19, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's pharmaceutical supply relationship with the...
- SPE2DB24D3015Indefinite Delivery Contract
- SPE2DB24D3015-SPE2DB25FGAVSDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Jardiance 10 mg tablets (90-count) with a ceiling value of $6,657.98. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The order is set for completion by September 5, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare systems worldwide. AmerisourceBergen, as a major pharmaceutical distributor, has demonstrated capability to meet federal medical procurement requirements through multiple contract awards with DLA, delivering critical medications including diabetes treatments, neurological drugs, pain management pharmaceuticals, and specialized medical supplies across therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 9/4/25 |